At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BEAT Heartbeam Inc
Trading 09-22 10:06:12 EDT
0.4448
+0.0138
+3.20%
High0.4500Low0.4357Vol195.79K
Open0.4400D1 Closing0.4310Amplitude3.32%
Mkt Cap25.06MTradable Cap21.18MTotal Shares56.35M
T/O86.80KT/O Rate0.41%Tradable Shares47.62M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

HeartBeam Announces Availability of Shareholder Letter
Reuters  ·  00:04
HeartBeam Announces Availability of Shareholder Letter
HeartBeam says redirecting resources to myocardial infarction detection
TIPRANKS  ·  09-21 20:50
HeartBeam says redirecting resources to myocardial infarction detection
Heartbeam, - Will not Build Large Commercial Organization for Arrhythmia Indication
THOMSON REUTERS  ·  09-21 20:31
Heartbeam, - Will not Build Large Commercial Organization for Arrhythmia Indication
Heartbeam, - Redirects Majority of Resources Toward Heart Attack Detection
THOMSON REUTERS  ·  09-21 20:31
Heartbeam, - Redirects Majority of Resources Toward Heart Attack Detection
HeartBeam Launches New At-The-Market Equity Offering
TIPRANKS  ·  08-15
HeartBeam Launches New At-The-Market Equity Offering
HeartBeam Enters ATM Equity Sales Agreement for up to $25 Million Common Stock Offering
Reuters  ·  08-15
HeartBeam Enters ATM Equity Sales Agreement for up to $25 Million Common Stock Offering
Heartbeam, Inc.: Enters into At-the-Market Equity Offering Sales Agreement for up to $25 Mln in Common Stock - SEC Filing
THOMSON REUTERS  ·  08-15
Heartbeam, Inc.: Enters into At-the-Market Equity Offering Sales Agreement for up to $25 Mln in Common Stock - SEC Filing
HeartBeam, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-14
HeartBeam, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
HeartBeam Q2 2026 results: Cash-burn outlook improves as net loss holds near $5 million
TradingKey  ·  08-14
HeartBeam Q2 2026 results: Cash-burn outlook improves as net loss holds near $5 million
HeartBeam Posts Q2 Presentation Outlining Heart Attack Detection Progress and Initial Commercial Launch Traction
Reuters  ·  08-14
HeartBeam Posts Q2 Presentation Outlining Heart Attack Detection Progress and Initial Commercial Launch Traction
HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance
Reuters  ·  08-14
HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance
HeartBeam Q2 Income from Operations USD -5.092 Million
Reuters  ·  08-14
HeartBeam Q2 Income from Operations USD -5.092 Million
HeartBeam Q2 EPS $(0.10) Misses $(0.09) Estimate
Benzinga Earnings  ·  08-14
HeartBeam Q2 EPS $(0.10) Misses $(0.09) Estimate
HeartBeam Q2 FY26 Net Loss Narrows to $5 Million; SG&A Expenses Rise to $2.76 Million
Reuters  ·  08-14
HeartBeam Q2 FY26 Net Loss Narrows to $5 Million; SG&A Expenses Rise to $2.76 Million
Heartbeam Q2 Net Income USD -5.039 Million
THOMSON REUTERS  ·  08-14
Heartbeam Q2 Net Income USD -5.039 Million
Heartbeam Baseline Q4 2026 Operating Cash Outflow is Expected to Step Down to Below $2.5 Million
THOMSON REUTERS  ·  08-14
Heartbeam Baseline Q4 2026 Operating Cash Outflow is Expected to Step Down to Below $2.5 Million
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  08-13
Calendar of U.S. Earnings Expected in the Week Ahead
HeartBeam, Inc. Expected to Post a Loss of 9 Cents a Share - Earnings Preview
Reuters  ·  08-12
HeartBeam, Inc. Expected to Post a Loss of 9 Cents a Share - Earnings Preview
HeartBeam Amends 8-K to Disclose Executed Separation, Advisory Agreements for Former Executive Eno
Reuters  ·  08-06
HeartBeam Amends 8-K to Disclose Executed Separation, Advisory Agreements for Former Executive Eno
HeartBeam Shareholders Shape Governance, Reject Equity Plan Expansion
TIPRANKS  ·  08-04
HeartBeam Shareholders Shape Governance, Reject Equity Plan Expansion

Introduction

Company Name.
Heartbeam Inc
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Issue price:
--